The HDAC2-DNMT3B-Bcl2 axis in gliomas is differentially expressed and interacting, HDAC2 activates the transcriptional activity of DNMT3B, and DNMT3B inhibits the expression of Bcl2. The gene discussed is DNMT3B; the disease is central nervous system cancer.